AdvaMed

Today’s #DeviceoftheWeek features the TULSA-PRO® system from Profound Medical Inc., a minimally invasive technique designed to treat prostate tissue. Utilizing directional ultrasound performed in a Magnetic Resonance Imaging (MRI) suite, it enables precise, physician-prescribed ablation of whole-gland or partial prostate tissue. The device is designed to meet individual patient needs and desired functional outcomes, making it a versatile option for patients seeking effective prostate treatment. Learn more about how Profound Medical Inc. is revolutionizing patient care in urology: https://lnkd.in/gBmfrnH

Gazelle is a point-of-care, in vitro diagnostic platform that uses #AI, innovative optics, and miniaturization to help diagnose diseases (including sickle cell and beta thalassemia) in underserved areas. Hemex Health, Inc. has distributed over 1.3 million tests for sickle cell disease in 38 countries and is now bringing Gazelle to the United States with the support of a National Institutes of Health grant. Sickle cell disease is most prevalent among African Americans and Hispanic Americans. Most individuals in the United States who possess the trait are not aware of it due to limited access to testing. Hemex is seeking a breakthrough device designation from the FDA to address this situation.

Great clip here that’s worth your time. Stephen MacMillan, of Hologic, Inc. and our AdvaMed board, lays out succinctly and convincingly the power of #AI already unfolding in health care settings around the world: Earlier and more accurate diagnoses than before AI was involved. And fewer false positives, which, as he points out, create not only unnecessary “angst” in patients but add costs to our system through unnecessary visits, tests, and days off work, and so on.    As Peter J Arduini of GE HealthCare and I pointed out in our recent op-ed, there is a lot of understandable concern about #AI’s role in our lives overall. We should be questioning AI carefully. People’s jobs and our children’s education are potentially at risk, to name just two big reasons to be skeptical. But one area where we should not be as concerned about AI is in #medtech. It is already saving lives, and it’s just the beginning. If you missed our op-ed, take a look here: https://lnkd.in/e-wCG75U

At this year’s The MedTech Conference, companies of all sizes will show how they’re at the forefront of #medtech innovation. A critical piece of creating groundbreaking technologies and inventive solutions is ensuring all patients have access to the diagnostics and treatment that could help them enjoy healthier lives. Don’t miss the opportunity to learn from the pioneers who are transforming the #medtech landscape to improve patient outcomes for all. #healthequity   Learn more: https://lnkd.in/ee5MAVGj  

Great to see #medtech finding an innovative way to meet a pressing need. Noting one of the biggest blood donation shortages in a generation, Abbott created a friendly competition among the millions of fans cheering on Big Ten college football this season. Why not tap into good-natured school rivalries and a high-profile football division to perform a public service?   Kudos to everyone at Abbott for taking on such a tremendously important cause in such a groundbreaking way, the first of its kind. One team will win the official award but everyone wins through what might become a lifelong generous habit for college student donors.    But you don’t have to be a student or even a football fan to donate blood and save lives. You can designate your donation to count toward your favorite Big Ten school. Go to bigten.org/abbott to learn more. #WeGiveBlood

AdvaMed salutes our leading #medtech member companies innovating breast cancer diagnostics and treatment to help millions of patients receive earlier diagnoses, leading to earlier treatment, and better outcomes.  

Our Abbott teams are going B1G for "The #WeGiveBlood Drive," a Big Ten Conference-wide blood donation competition! The Cornhuskers have been a-maize-ing so far, leaving the other schools in their dust. Which school is coming for them? Pick your favorite and help them rise to the top at BigTen.Org/Abbott.

Today’s #DeviceOfTheWeek features Sleep WISP Therapy from Neurosom® Sleep Therapy of Eugene, Oregon. Neurosom’s Sleep WISP Therapy is applied by the user, at home, through a headband worn during sleep. The headband system uses EEG and machine learning to accurately track the user’s sleep cycles. The system applies painless electrical stimulation to facilitate sleep onset as well as extend and enhance deep sleep. The technology is supported by Department of Defense and National Institutes of Aging grants to improve deep sleep and cognitive functions in military service members and seniors. Neurosom plans to seek a breakthrough device designation from the FDA, which would help promote access to patients.

AdvaMed staff were excited to attend the Alliance for Aging Research 2024 Heroes in Health Celebration. AdvaMed's Senior Vice President for State Affairs & Head of Alliance Development, Bobby Patrick, VI, had the honor of presenting the Silver Innovator Award to Jeffrey Cummings, MD, ScD, at this year's annual awards dinner. Dr. Cummings is internationally recognized for his significant contributions to Alzheimer’s research, drug development, and clinical trials. We are grateful for our partnership with the Alliance for Aging Research and its commitment to achieving healthy aging and equitable access to care for patients around the world. #HeroesinHealth

ICYMI: AdvaMed’s President and CEO Scott Whitaker and GE HealthCare President and CEO Peter J Arduini shared insights on how #medtech AI innovation is paving the way for better health outcomes. Read more about the transformative impacts of #AI in health care. https://lnkd.in/ecTKSAKN